BioCryst Pharmaceuticals ... (BCRX)
undefined
undefined%
At close: undefined
7.50
-0.07%
After-hours Dec 13, 2024, 06:55 PM EST

BioCryst Pharmaceuticals Inc. Forcast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for BCRX stock have an median target of 12, with a low estimate of 8 and a high estimate of 16. The median target predicts an increase of 60.00% from the current stock price of 7.50.

Analyst Consensus: Buy
Target Low Average Median High
Price $8 $12 $12 $16
Change 6.67% 60.00% 60.00% 113.33%

AI Analyst Report

RBC Capital maintains an Outperform rating on BioC... Unlock content with Pro Subscription

Updated Nov 05, 2024

Rating Jan 24Apr 24May 24Aug 24Nov 24
Strong Buy 00000
Buy 11332
Hold 00011
Sell 00000
Strong Sell 00000
Total 1 1 3 4 3

Financial Forecast this Year

Revenue This Year
429.97M
from 331.41M
Increased by 29.7%
Revenue Next Year
516.71M
from 429.97M
Increased by 20.2%
EPS This Year
-0.41
from -1.18
Increased by 65.3%
EPS Next Year
-0.2
from -0.41
Increased by 51.2%